TNF and inflammatory bowel disease: Despite several case reports detailing the development of HSTCL in CD patients, it has not been possible to determine if the anti-TNF-α agents played a primary role in the lymphomagenesis or if HSTCL should be regarded as the result of a clonal evolution within the more generalised chronic inflammatory processes that characterise IBD.